NVP-BEZ235, a dual inhibitor of PI3K and mTOR, induces MAPK phosphorylation in HER2 positive cells

被引：0
|
作者：
Serra, Violeta [1 ]
Eichhorn, Pieter [1 ]
Scaltriti, Maurizio [1 ]
Prudkin, Ludmila [1 ]
Rodriguez, Olga [1 ]
Guzman, Marta [1 ]
Baselga, Jose [1 ]
机构：
[1] Vall dHebron Inst Oncol, Barcelona, Spain
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-52
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dual PI3K/mTOR Inhibitor NVP-BEZ235 Sensitizes Docetaxel in Castration Resistant Prostate Cancer
    Yasumizu, Yota
    Miyajima, Akira
    Kosaka, Takeo
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2014, 191 (01): : 227 - 234
  • [22] NVP-BEZ235, A Dual PI3K/mTOR Inhibitor, Enhances Chemotherapy and Antiangiogenic Response in Pancreatic Cancer
    Ostapoff, K. T.
    Awasthi, N.
    Yen, P. L.
    Zhang, C.
    Schwarz, M. A.
    Brekken, R. A.
    Schwarz, R. A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S46 - S46
  • [23] Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib
    Didier Roulin
    Laurent Waselle
    Anne Dormond-Meuwly
    Marc Dufour
    Nicolas Demartines
    Olivier Dormond
    Molecular Cancer, 10
  • [24] NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations
    Serra, Violeta
    Markman, Ben
    Scaltriti, Maurizio
    Eichhorn, Pieter J. A.
    Valero, Vanesa
    Guzman, Marta
    Luisa Botero, Maria
    Llonch, Elisabeth
    Atzori, Francesco
    Di Cosimo, Serena
    Maira, Michel
    Garcia-Echeverria, Carlos
    Lluis Parra, Josep
    Arribas, Joaquin
    Baselga, Jose
    CANCER RESEARCH, 2008, 68 (19) : 8022 - 8030
  • [25] Dual PI3K/mTOR inhibitor NVP-BEZ235 in combination with AKT inhibitor MK2206 in esophageal carcinoma cells
    Yu, Hao
    Shi, Ni
    Pan, Zui
    Chen, Tong
    CANCER RESEARCH, 2014, 74 (19)
  • [26] NVP-BEZ235, a dual PI3K/mTOR inhibitor synergistically potentiates the antitumor effects of cisplatin in bladder cancer cells
    Moon, Du G.
    Lee, Sang E.
    Oh, Mi M.
    Lee, Sang C.
    Jeong, Seong J.
    Hong, Sung K.
    Yoon, Cheol Y.
    Byun, Seok S.
    Park, Hong S.
    Cheon, Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (03) : 1027 - 1035
  • [27] Discovery of NVP-BEZ235 - A dual PI3K/mTOR inhibited for targeted cancer treatment
    Garcia-Echeverria, Carlos
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (07) : 697 - 698
  • [28] NVP-BEZ235, A DUAL PI3K/MTOR INHIBITOR SYNERGISTICALLY POTENTIATES ANTITUMOR EFFECT OF CISPLATIN IN BLADDER CANCER CELLS
    Park, Hong Seok
    Yoon, Cheol Yong
    Cheon, Jun
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A206 - A206
  • [29] NVP-BEZ235, a dual PI3K/mTOR inhibitor, suppress tumorigenicity of ovarian clear cell carcinoma cells.
    Oishi, Tetsuro
    Itamochi, Hiroaki
    Kudoh, Akiko
    Nonaka, Michiko
    Sato, Seiya
    Naniwa, Jun
    Sato, Shinya
    Shimada, Muneaki
    Terakawa, Naoki
    Kigawa, Junzo
    Harada, Tasuku
    CANCER RESEARCH, 2012, 72
  • [30] NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
    Wen-juan Wang
    Lin-mei Long
    Neng Yang
    Qing-qing Zhang
    Wen-jun Ji
    Jiang-hu Zhao
    Zheng-hong Qin
    Zhong Wang
    Gang Chen
    Zhong-qin Liang
    Acta Pharmacologica Sinica, 2013, 34 : 681 - 690
12345